These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 4062433)

  • 1. Cholinergic and pancreatic actions of purified porcine and synthetic vasoactive intestinal peptide (VIP).
    Blitz W; Beijer HJ; Charbon GA
    Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):66-76. PubMed ID: 4062433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of VIP/PACAP family of peptides on pancreatic blood flow and secretion in conscious dogs.
    Ito O; Naruse S; Kitagawa M; Ishiguro H; Ko S; Nakajima M; Hayakawa T
    Regul Pept; 1998 Nov; 78(1-3):105-12. PubMed ID: 9879753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic response of the pancreas to synthetic chicken VIP in dogs.
    Inoue K; Suzuki T; Tobe T; Yajima H
    Endocrinol Jpn; 1980 Dec; 27 Suppl 1():65-9. PubMed ID: 7227321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of synthetic chicken vasoactive intestinal peptide on pancreatic blood flow and on exocrine and endocrine secretions of the pancreas in dogs.
    Inoue K; Kawano T; Shima K; Kim T; Suzuki T; Tobe T; Takeyama M; Yajima H
    Dig Dis Sci; 1983 Aug; 28(8):724-32. PubMed ID: 6347571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-response effects of VIP on the rabbit exocrine pancreatic secretion. Comparison with PACAP-27 actions.
    Rodríguez-López AM; De Dios I; García LJ; López MA; Calvo JJ
    Rev Esp Fisiol; 1995 Mar; 51(1):29-36. PubMed ID: 7569277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of synthetic and natural vasoactive intestinal peptide on pancreatic and biliary secretion and on glucose and insulin blood levels in the dog.
    Makhlouf GM; Yau WM; Zfass AM; Said SI; Bodanszky M
    Scand J Gastroenterol; 1978; 13(6):759-65. PubMed ID: 694415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between development of fibrosis and hemodynamic changes of the pancreas in dogs.
    Inoue K; Kawano T; Shima K; Suzuki TK; Tobe T; Yajima H
    Gastroenterology; 1981 Jul; 81(1):37-47. PubMed ID: 7239124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional vascular influences of vasoactive intestinal polypeptide.
    Blitz W; Charbon GA
    Scand J Gastroenterol; 1983 Sep; 18(6):755-63. PubMed ID: 6669940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of vasoactive intestinal polypeptide on the canine cardiovascular system.
    Unverferth DV; O'Dorisio TM; Muir WW; White J; Miller MM; Hamlin RL; Magorien RD
    J Lab Clin Med; 1985 Nov; 106(5):542-50. PubMed ID: 4056568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of synthetic chicken and porcine vasoactive intestinal peptide on pancreatic blood flow in dogs.
    Inoue K; Suzuki T; Tobe T; Yajima H
    Neuropeptides; 1986 Apr; 7(3):207-17. PubMed ID: 3713993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile secretion in man. The effects of somatostatin, vasoactive intestinal peptide and secretin.
    Nyberg B
    Acta Chir Scand Suppl; 1990; 557():1-40. PubMed ID: 1981635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoactive intestinal peptide in cirrhotic rats: hemodynamic effects and mesenteric arterial receptor characteristics.
    Lee SS; Huang M; Ma Z; Rorstad O
    Hepatology; 1996 May; 23(5):1174-80. PubMed ID: 8621151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic AMP and bicarbonate responses of the dog pancreas to vasoactive intestinal peptide (VIP) and secretion.
    Konturek SJ; Domschke S; Domschke W; Dembiński A; Król R; Demling L
    J Lab Clin Med; 1976 Oct; 88(4):608-13. PubMed ID: 184219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VIP and its homologues increase vascular conductance in certain endocrine and exocrine glands.
    Huffman LJ; Connors JM; Hedge GA
    Am J Physiol; 1988 Apr; 254(4 Pt 1):E435-42. PubMed ID: 3354661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of helodermin, VIP and PHI in pancreatic secretion and blood flow in dogs.
    Konturek SJ; Yanaihara N; Pawlik W; Jaworek J; Szewczyk K
    Regul Pept; 1989 Feb; 24(2):155-66. PubMed ID: 2922493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoactive intestinal peptide: a secretin-like partial agonist for pancreatic secretion in man.
    Domschke S; Domschke W; Rösch W; Konturek SJ; Sprügel W; Mitznegg P; Wünsch E; Demling L
    Gastroenterology; 1977 Sep; 73(3):478-80. PubMed ID: 892345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoactive intestinal polypeptide increases whole pancreatic blood flow but does not affect islet blood flow in the rat.
    Jansson L
    Acta Diabetol; 1994 Jun; 31(2):103-6. PubMed ID: 7949220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of substance P on CCK- or VIP-induced choleresis in anesthetized dogs.
    Magnusson I; Thulin L
    Acta Physiol Scand; 1979 Jul; 106(3):293-7. PubMed ID: 41410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of renin secretion by vasoactive intestinal peptide.
    Porter JP; Reid IA; Said SI; Ganong WF
    Am J Physiol; 1982 Sep; 243(3):F306-10. PubMed ID: 7051858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of cholecystokinin receptors in the regulation of the circulation and oxygen consumption in the pancreas].
    Gustaw P; Samborska M; Pawlik WW; Konturek SJ
    Folia Med Cracov; 1990; 31(1-2):45-56. PubMed ID: 2210484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.